Avandia and Byetta- vtap mobile videos

A new study of Glaxo's Avandia shows the drug raises the risk of fatal heart disease, with Mike Huckman, CNBC pharmaceuticals reporter

2m 16s |

2 years ago

CNBC Video Gallery - CNBC.com

Keep this video in the "Saved" list

Now, put vTap to work for you!

Let us keep you up to date with new videos related to:

CNBC

GlaxoSmithKline

Go to Feed to see what's new!

share

keep

Nissen, Cardiologist, `Satisfied' with Vote on Glaxo's Avandia

...GlaxoSmithKline ...diabetes pill Avandia and the safety of Takeda Pharmaceutical Co.'s Actos. The panel decided that Avandia should remain on the market but be accompanied by new safety warnings. ...

2 years ago

Bloomberg - Financial News

Keep this video in the "Saved" list

Now, put vTap to work for you!

Let us keep you up to date with new videos related to:

Food and Drug Administration

GlaxoSmithKline

Cleveland Clinic

Pharmaceutical company

Steven Nissen

Rosiglitazone

Gaithersburg, Maryland

Go to Feed to see what's new!

share

keep

Graham of FDA Says Takeda's Actos Is Safer Than Glaxo's Avandia

...GlaxoSmithKline ...Avandia diabetes drug versus Takeda Pharmaceutical Co.'s Actos. Graham told a meeting of FDA advisers today that Avandia should be removed from the market because of heart risks....

2 years ago

Bloomberg - Financial News

Keep this video in the "Saved" list

Now, put vTap to work for you!

Let us keep you up to date with new videos related to:

Food and Drug Administration

GlaxoSmithKline

Pharmaceutical company

United Kingdom

Pioglitazone

Gaithersburg, Maryland

David Graham (epidemiologist)

Go to Feed to see what's new!

share

keep

Tech Talk: GSK Pays Stiff Price for Diabetes Drug Controversy

... the New England Journal of Medicine talks, people listen. Just ask GlaxoSmithKline about the diabetes drug Avandia. Its sales have plummeted in recent weeks after a NEJM study raised safety ...

2 years ago

WRAL

Keep this video in the "Saved" list

Now, put vTap to work for you!

Let us keep you up to date with new videos related to:

Rosiglitazone

GlaxoSmithKline

New England Journal of Medicine

New England

Go to Feed to see what's new!

share

keep

GSK Earnings Preview

Falling sales in key diabetes drug Avandia and a falling dollar could affect GlaxoSmithKline's second-quarter earnings that are due out Wedn...

4m 39s |

2 years ago

CNBC Video Gallery - CNBC.com

Keep this video in the "Saved" list

Now, put vTap to work for you!

Let us keep you up to date with new videos related to:

Rosiglitazone

GlaxoSmithKline

Go to Feed to see what's new!

share

keep